标题
Recent developments of RNA-based vaccines in cancer immunotherapy
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume -, Issue -, Pages 1-18
出版商
Informa UK Limited
发表日期
2020-08-26
DOI
10.1080/14712598.2020.1815704
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma
- (2020) Robert A. Figlin et al. CLINICAL CANCER RESEARCH
- Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
- (2020) Alexey V. Baldin et al. Cancers
- Amplifying RNA Vaccine Development
- (2020) Deborah H. Fuller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
- (2019) Alexandros Papachristofilou et al. Journal for ImmunoTherapy of Cancer
- A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
- (2019) Martin Sebastian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
- (2019) Anna K. Blakney et al. GENE THERAPY
- Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
- (2019) Lei Miao et al. NATURE BIOTECHNOLOGY
- Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
- (2019) Maria L. Guevara et al. ACS Omega
- Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination
- (2018) Satoshi Uchida et al. BIOMATERIALS
- Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells
- (2018) A. Le Moignic et al. JOURNAL OF CONTROLLED RELEASE
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
- (2018) Annette B. Vogel et al. MOLECULAR THERAPY
- mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
- (2018) Yuhua Wang et al. MOLECULAR THERAPY
- Recent advances in mRNA vaccine delivery
- (2018) Lu Tan et al. Nano Research
- Engineering circular RNA for potent and stable translation in eukaryotic cells
- (2018) R. Alexander Wesselhoeft et al. Nature Communications
- Targeting Head and Neck Cancer by Vaccination
- (2018) Chuan Wang et al. Frontiers in Immunology
- Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
- (2018) Robert A. Jabulowsky et al. CANCER RESEARCH
- Scaffold-mediated delivery for non-viral mRNA vaccines
- (2018) Ruying Chen et al. GENE THERAPY
- mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
- (2018) Ole A. W. Haabeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
- (2018) Lien Van Hoecke et al. Nature Communications
- Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine
- (2018) Ya-Nan Fan et al. Biomaterials Science
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
- (2018) Alexandra G. Orlandini von Niessen et al. MOLECULAR THERAPY
- mRNA therapeutics deliver a hopeful message
- (2018) Zifu Zhong et al. Nano Today
- Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins
- (2017) Tim Beissert et al. HUMAN GENE THERAPY
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
- (2017) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
- (2016) O. Tu reci et al. CLINICAL CANCER RESEARCH
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma
- (2016) Stephan Grabbe et al. Nanomedicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- A Universal Code for mRNA Stability?
- (2016) Ying-Hsin Chen et al. TRENDS IN GENETICS
- Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
- (2016) Aleksandra Kowalczyk et al. VACCINE
- Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
- (2016) Lukasz Bialkowski et al. Scientific Reports
- Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
- (2016) Jon Amund Kyte et al. OncoImmunology
- Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma
- (2015) Elnaz Faghfuri et al. Expert Review of Anticancer Therapy
- A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
- (2015) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF CANCER
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy
- (2015) Susanne M. Rittig et al. OncoImmunology
- Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
- (2015) Kalijn F Bol et al. OncoImmunology
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
- (2015) Michael A Morse et al. Journal for ImmunoTherapy of Cancer
- Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
- (2015) Asim Amin et al. Journal for ImmunoTherapy of Cancer
- Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
- (2015) Kevin Van der Jeught et al. Oncotarget
- Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
- (2014) Sandra Van Lint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Electroporation-enhanced delivery of nucleic acid vaccines
- (2014) Kate E Broderick et al. Expert Review of Vaccines
- mRNA-based dendritic cell vaccines
- (2014) Daphné Benteyn et al. Expert Review of Vaccines
- mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
- (2014) Mariola Fotin-Mleczek et al. Radiation Oncology
- mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
- (2014) Steffen Rausch et al. Human Vaccines & Immunotherapeutics
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Modulation of Regulatory T Cell Function by Monocyte-Derived Dendritic Cells Matured through Electroporation with mRNA Encoding CD40 Ligand, Constitutively Active TLR4, and CD70
- (2013) J. J. Pen et al. JOURNAL OF IMMUNOLOGY
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
- (2012) Mariola Fotin-Mleczek et al. JOURNAL OF GENE MEDICINE
- Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
- (2012) An MT Van Nuffel et al. MOLECULAR THERAPY
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
- (2012) Susan F. Slovin et al. VACCINE
- FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
- (2011) S. Kreiter et al. CANCER RESEARCH
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
- (2011) B. R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Potency of Mature CD40L RNA Electroporated Dendritic Cells Correlates With IL-12 Secretion by Tracking Multifunctional CD8+/CD28+ Cytotoxic T-cell Responses In Vitro
- (2010) Mark A. DeBenedette et al. JOURNAL OF IMMUNOTHERAPY
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
- (2008) M. de la Luz Garcia-Hernandez et al. CANCER RESEARCH
- Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells
- (2008) Hetty J. Bontkes et al. CLINICAL IMMUNOLOGY
- A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy
- (2008) D Hoang-Le et al. GENE THERAPY
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now